The first quarter of 2025 was challenging for Moderna, with shares sliding 31.8% as the S&P 500 and Nasdaq Composite also saw losses. The company’s revenues plummeted, leading to a significant decline in sales and lowered guidance for 2025. The resignation of FDA official Peter Marks added to investor concerns, with analysts warning of potential delays in Moderna’s vaccine development programs.
Full Article
The Best Stocks to Invest $50,000 in Right Now
If you have $50,000 to invest, it's a great opportunity to enhance your retirement or achieve other financial goals. There are several low-risk stocks available that can provide growth, making it important to explore these options further. Explain It To Me Like I'm 5: If you have $50,000, you can buy things that will help your money grow safely, like special pieces of a company called stocks. Need More Context? 🔎
Read more